Explore the groundbreaking AI genomics platform, Inference, launched by Variant Bio to enhance drug discovery using genetic ...

A new study published in Ecology Letters has uncovered the mechanisms underlying plant community assembly and biodiversity ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...

LAHORE: Artificial intelligence (AI) is enabling researchers to uncover new cancer applications for widely used medicines by ...

Meta-analysis shows diabetes increases male infertility risk, with inflammation identified as a key underlying mechanism.

Novel research led by Brazilian scientists describes the immune system's reactions in detail in the first living patient to ...

Variant Bio, a genomics-driven AI drug discovery company, today announced the launch of Inference, the world's first agentic genomic drug dis ...

According to the authors, Host Defense Lion's Mane mushroom mycelium powder supported a broad range of immune- and oxidative stress--related pathways while exhibiting comparatively lower inflammatory ...

The maternal microbiome and immune system have both independent and synergistic effects on fetal brain health—changes in the ...

Explore how AI-driven multiomics is reshaping drug discovery and personalized medicine development through innovative data ...